Melya Hughes Crameri

Managing Director

2010 - Current

Company Building, Corporate Development, Strategy, Investment

Partner

2015 - 2023

Ventac Partners work to advance healthcare and biotechnology innovations and create the maximum value for inventors and investors. We offer proven CEO and Board Member experience and assistance to start-up biotechnology businesses and IPO candidates.

Non Executive Director

2017 - 2019

LSHW is a company limited by guarantee and a wholly-owned subsidiary of the Welsh Government, supporting engagement from the public and private sector to develop opportunities for improved health and wellbeing.

Founder & CEO

2011 - 2013

Caltherix Inc. - microprotein therapeutics addressing GPCRs and ion channel targets in pain and oncology

Chief Executive Officer (US) and Executive Management (CH)

2005 - 2010

President & CEO, Genetic Chemistry Inc. (Evolva US) (May 2008- June 2010) Founder, Genetic Chemistry Inc. (Evolva US) (April 2007- April 2008) VP Alliances & IP, Evolva SA (March 2005 - April 2008) Evolva/Genetic Chemistry Inc. was focused on synthetic biology approaches to discover and develop small molecule therapeutics (anti-infectives).

Business & IP Strategy Consultant

2004 - 2005

Head of Licensing & Patents

1999 - 2003

The FMI (Novartis Research Foundation) is a center for biomedical research with about 20 research groups and over 250 staff, with focus areas including oncology, metabolic disease, neurosciences, epigenetics and agribusiness.

Patent Counsel

1998 - 1999

Geron focused on stem cell therapies and inhibition of telomerase (oncology).

Patent Agent

1993 - 1998

Research Scientist

1990 - 1992